"We have an available organ." Thousands of people never live long enough to hear those words. In fact, in the United States, ...

27 April 2025, Boston—In places like Australia, where metropolitan areas are separated by an entire continent, donor hearts used to go unused simply because transplant teams couldn’t get the organ to ...

The total number of patients enrolled across both parts is anticipated to exceed 650.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. LivaNova announced it received FDA 510(k) clearance for ...

Read full article: Navigating HPV vaccine hesitancy: A doctor debunks myths, encourages cancer prevention Dr. Kyle Miletic, surgeon, talks about the procedure with heart transplant recipient Ken ...

A new medical technology expected to be on the market in 2027 is poised to help patients in middle America have greater access to heart transplants. Xvivo Perfusion, a leader in organ transplant ...

LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance ...

Please provide your email address to receive an email when new articles are posted on . The use of normothermic regional perfusion could injure donor lungs meant for transplantation. More research is ...

LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance and CE Mark for ...

Lung transplant is usually done in patients with non-malignant advanced or end-stage pulmonary diseases (such as severe pulmonary fibrosis, cystic fibrosis, pulmonary hypertension and obliterative ...